Literature DB >> 16282504

Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.

Marja J Verhoef1, Lynda G Balneaves, Heather S Boon, Annette Vroegindewey.   

Abstract

PURPOSE: To conduct a systematic review of reasons for and sociodemographic and disease characteristics associated with complementary and alternative medicine (CAM) use in cancer patients.
METHODS: Eligible studies were identified by searching the following databases: Alt Health Watch, AMED, CINAHL, CancerLit, PremMEDLINE, MEDLINE, Pub-Med, Ingenta, EMBASE, and Health Star, as well as reference lists in review articles. Only English-language articles published between 1994 and 2004 were included. Search terms included CAM and oncology/cancer, decision making and CAM and oncology/cancer, treatment decision making and CAM and oncology/cancer, and health care choices and CAM and oncology/cancer.
RESULTS: Fifty-two eligible studies were identified and summarized. These studies were conducted in 14 different countries, with the largest number of studies being completed in the United States (34.6%). A therapeutic response, wanting control, a strong belief in CAM, CAM as a last resort, and finding hope were the most commonly cited reasons for using CAM. Age, socioeconomic status, and gender were the dominant characteristics associated with CAM use.
CONCLUSION: Reasons for and characteristics associated with CAM use among cancer patients have been studied extensively. Future CAM research among cancer patients should focus on identifying decision-making processes and building theoretical decision-making models. These can be used in the development of decisional aids for patients when confronted with the choice to use CAM as part of their cancer treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16282504     DOI: 10.1177/1534735405282361

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  81 in total

1.  Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer.

Authors:  Catalina Lawsin; Katherine DuHamel; Steven H Itzkowitz; Karen Brown; Helen Lim; Linda Thelemaque; Lina Jandorf
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

2.  Cancer and complementary medicine: an international perspective.

Authors:  Vinjar Fønnebø; Marja Verhoef; Charlotte Paterson
Journal:  Support Care Cancer       Date:  2007-07-03       Impact factor: 3.603

3.  Introduction to section on integrative oncology.

Authors:  Barrie R Cassileth; Kathleen Wesa
Journal:  Curr Treat Options Oncol       Date:  2008-08-08

4.  Intentions to use hypnosis to control the side effects of cancer and its treatment.

Authors:  Stephanie J Sohl; Lauren Stossel; Julie B Schnur; Kristin Tatrow; Amfiana Gherman; Guy H Montgomery
Journal:  Am J Clin Hypn       Date:  2010-10

5.  Complementary and alternative medicine: what the public want and how it may be delivered safely and effectively.

Authors:  George Lewith; Nicola Robinson
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

6.  Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States.

Authors:  Nina N Sanford; David J Sher; Chul Ahn; Ayal A Aizer; Brandon A Mahal
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

7.  Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Britt Wanta
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

8.  Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II.

Authors:  Chin-Cheng Su
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

9.  Evaluating complex health interventions: a critical analysis of the 'outcomes' concept.

Authors:  Charlotte Paterson; Charlotte Baarts; Laila Launsø; Marja J Verhoef
Journal:  BMC Complement Altern Med       Date:  2009-06-18       Impact factor: 3.659

10.  Diagnoses and visit length in complementary and mainstream medicine.

Authors:  Phil J M Heiligers; Judith de Groot; Dick Koster; Sandra van Dulmen
Journal:  BMC Complement Altern Med       Date:  2010-01-25       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.